ClinicalTrials.gov
public full text
Public Domain
Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device
The VOYAGER Study is an interventional, non-randomized, single-arm, dose escalation trial with the goal of determining the safety of TheraSphere PCa device in patients with clinically localized prostate cancer across US-based centers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer#893881
- Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer#877642
- PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC#1381936
- Chemotherapy in Treating Patients With Prostate Cancer#1137977
- Early-access Use of Radioligand Therapy in Prostate Cancer#288064
Record · ID 1439115
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive